Opinion|Videos|July 29, 2024
Biosimilars in the Commercial Sector
Dr. Cannon discusses payers and PBMs making decisions about biosimilars in the commercial sector.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How are payers and PBMs making decisions about biosimilars in the commercial sector?
a. What key factors are considered for formulary decisions in the commercial sector?
b. Discussion points: What makes the commercial sector unique, employer/payer payment models.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds
2
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
3
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
4
Endometriosis Reduces Ovarian Reserve via Inflammation and Surgery
5